April 9-12, 2025
Delphi Economic Forum X
Professor of Therapeutics of Hematology-Oncology, Department of Clinical Therapeutics (Alexandra Hospital), School of Medicine
National and Kapodistrian University of Athens, Athens, GreeceDepartment of Medicine, Korea University, Seoul, South Korea, Greece
Meletios A. Dimopoulos, MD is Professor and Chairman of the Department of Clinical Therapeutics at the National and Kapodistrian University of Athens School of Medicine, Athens, Greece. He was the Rector of the National and Kapodistrian University of Athens from February 2015 until August 2023. He has been a member of the Board of the International Myeloma Society and the chairman of the Greek Myeloma Study Group. Currently he is the chairman of the Balkan Myeloma Study Group, a member of the Board of the European Myeloma Network, a member of the scientific committee of the European School of Haematology, a member of the SOHO educational committee and a member of the Editorial Board of Expert Review of Hematology. As of January 2025 he has published more than 1450 manuscripts in Peer Review Journals and his h-index (Google Scholar) is 173. His particular interest is in hematologic malignancies (especially plasma cell dyscracias) and solid tumors. He is a recipient of the Robert A. Kyle Award for outstanding contributions to Waldenstrom’s macroglobulinemia (May 2003), a recipient of Waldenstrom's award for Myeloma Research of the International Myeloma Society (March 2017), recipient of the CoMy Excellence Award (May 2017). In August 2017 he was given the title "Officier dans l' Ordre des Palmes academiques" (Republique Francaise, Ministere de l' Education Nationale). In May 2018 he was elected as “membre associe etranger” of the National Academy of Medecine of France. He also received The Robert Kyle Life Achievement Award (June 2019), Distinguished Alumnus Award from the MD Anderson Cancer Centre, Houston, TX, USA (January 2020), Medal of the Grand Commander of the Order of the Phoenix awarded by the President of the Hellenic Republic (February 2020) and the Title of Doctor Honoris Causa by the University of Belgrade (October 2022).
Title, Company, Country